All > Massachusetts Investigators

Corrine K Welt, MD

Massachusetts General Hospital

Boston, Massachusetts - 02114

CLINICAL TRIALS 4
CONDITIONS1
INTERVENTIONS2
SINCE2003

Recombinant Human Prolactin for Lactation Induction

September 2004 - September 2010

The Genetics of Polycystic Ovarian Syndrome

January 2003 -

Recombinant Human Prolactin for Lactation Induction

September 2006 -

Recombinant Human Prolactin for Lactation Induction

January 2005 -

Polycystic Ovary Syndrome

Normal Saline

Recombinant Human Prolactin

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Corrine K Welt, MD

Massachusetts General Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP